Treeway
Frank Ruwe is a seasoned professional in clinical operations and medical research with extensive experience across various high-level roles. Currently serving as Clinical Operations Lead at Treeway and Sr Consultant Clinical Operations at 3D-PharmXchange, Frank previously held positions such as Sr Manager Clinical Affairs at Thermo Fisher Scientific and Associate Director of Global Trial Management at Merck / MSD. Frank has demonstrated leadership as Chairman of the supervisory board for both Culture Center Theatre De Kattendans and Rietveld & Ruys Foundation. An accomplished leader in clinical development, Frank has a strong background in clinical trial management, evidenced by achievements such as securing De Novo approval for digital pathology at Philips. Frank holds a Master of Science in Medical Biology from Utrecht University, a Master's in Pharmaceutical Medicine from the University of Basel, and a BA in Dentistry from Radboud University.
This person is not in any teams
This person is not in any offices
Treeway
Treeway is a clinical-stage biotech company developing therapy for ALS, Alzheimer's Disease and other neurodegenerative diseases. Treeway has been formed by the words tree of life and pathway of a disease, for the founders the symbolic way towards a cure. We foresee that medication, research and care will change dramatically in the coming decades and patients will become an essential part of this process on their pursuit for cures in rare and common diseases. Everyone can make a difference and our slogan "one man can and will find a way, why not be that man?" underpins our drive.